SSGJ-626
SSGJ‑626 is a BDCA-2 targeting monoclonal antibody that targets plasmacytoid dendritic cells. SSGJ‑626 can be used in research related to systemic lupus erythematosus.
Para uso exclusivo en investigación. No vendemos a pacientes.
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Species Reactivity
Human
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Target
BDCA2
Conjugated
Unconjugated
Aplicación
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
[SSGJ-626]
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)